Application no. and date | 08749449.8 (espacenet) (Federated) (European Patent Register), 20080514 | Patent/reg. no. and date | DK/EP 2155663, 20171129 | Publication date | 20100224 | Priority no. and date | EP 07011766, 20070615 | EP pub. no. and date |
EP 2155663 20100224 | Effective date | | Applicant/owner | Newron Pharmaceuticals S.p.A., Via Ariosto, 21
20091 Bresso (MI), IT | Applicant ref. no. | P81704779DK00E | Inventor | MELLONI, Piero, Via G. Centurelli 1
I-20091 Bresso, IT, RESTIVO, Alessandra, Via Domenichino, 2
I-20149 Milano, IT, IZZO, Emanuela, Via Gaetana Agnesi, 10
I-20100 Milano, IT, FRANCISCONI, Simona, Via Carnia, 20
I-20132 Milano, IT, COLOMBO, Elena, Via Buonarroti, 2
I-22044 Inverigo, IT, SABIDO-DAVID, Cibele, Via Carlo de Cristoforis, 13
I-20124 Milano, IT | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/165 (2006.01) , C07C 237/06 (2006.01) , C07D 295/182 (2006.01) | Title | SUBSTITUEREDE 2-[2-(PHENYL)ETHYLAMINO]ALKANAMIDDERIVATER OG DERES ANVENDELSE SOM NATRIUM- OG/ELLER KALCIUMKANALMODULATORER | Int. application no. | EP2008003848 | Int. publication no. | WO2008151702 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|